Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy

LA Smith, F Azariah, VTC Lavender… - Cochrane Database …, 2015 - cochranelibrary.com
Background Cannabis has a long history of medicinal use. Cannabis‐based medications
(cannabinoids) are based on its active element, delta‐9‐tetrahydrocannabinol (THC), and …

Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities

S Lal, A Shekher, AS Narula, H Abrahamse… - Pharmacological …, 2021 - Elsevier
Cannabis has long been used for healing and recreation in several regions of the world.
Over 400 bioactive constituents, including more than 100 phytocannabinoids, have been …

Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse

SP Sontineni, S Chaudhary… - World journal of …, 2009 - pmc.ncbi.nlm.nih.gov
Cannabis is a common drug of abuse that is associated with various long-term and short-
term adverse effects. The nature of its association with vomiting after chronic abuse is …

The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana …

M Soriano-Co, M Batke, MS Cappell - Digestive diseases and sciences, 2010 - Springer
Abstract Goals/Background The cannabis hyperemesis syndrome, which is associated with
chronic cannabis use, was recently reported in seven case reports and one clinical series of …

Cannabinoid hyperemesis relieved by compulsive bathing

YH Chang, DM Windish - Mayo Clinic Proceedings, 2009 - Elsevier
Cannabinoid hyperemesis is a clinical syndrome characterized by repeated vomiting and
associated learned compulsive hot water bathing behavior due to long-term marijuana use …

A neutral CB1 receptor antagonist reduces weight gain in rat

AP Chambers, VK Vemuri, Y Peng… - American Journal …, 2007 - journals.physiology.org
Cannabinoid (CB) 1 receptor inverse agonists inhibit food intake in animals and humans but
also potentiate emesis. It is not clear whether these effects result from inverse agonist …

The abuse potential of the synthetic cannabinoid nabilone

MA Ware, E St Arnaud‐Trempe - Addiction, 2010 - Wiley Online Library
Aim Nabilone is a synthetic cannabinoid prescription drug approved in Canada since 1981
to treat chemotherapy‐induced nausea and vomiting. In recent years, off‐label use of …

Novel benzimidazole derivatives as selective CB2 agonists

D Pagé, E Balaux, L Boisvert, Z Liu, C Milburn… - Bioorganic & medicinal …, 2008 - Elsevier
The preparation and evaluation of a novel class of CB2 agonists based on a benzimidazole
moiety are reported. They showed binding affinities up to 1nM towards the CB2 receptor with …

Diagnosis and acute management of adolescent cannabinoid hyperemesis syndrome: a systematic review

JW Zhu, CL Gonsalves, RM Issenman… - Journal of Adolescent …, 2021 - Elsevier
Purpose This study aimed to synthesize qualitative and quantitative data on the diagnosis
and effective management of cannabinoid hyperemesis syndrome (CHS) in the adolescent …